Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Purushe
Durable Responses After CD19-targeted CAR-T Cell Immunotherapy With Concurrent Ibrutinib for CLL After Prior Ibrutinib Failure
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High Rate of Durable Complete Remission in Follicular Lymphoma After Cd19 Car-T Cell Immunotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Toxicities of CD19 CAR-T Cell Immunotherapy
American Journal of Hematology
Hematology
First-Line Ibrutinib Confirmed for CLL
Cancer Discovery
Oncology
Ibrutinib May Boost Efficacy of CAR T Cells
Cancer Discovery
Oncology
Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T Cells Alone or in Combination With Ibrutinib for Relapsed and/or Refractory CLL
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
MDS as a Cause for Prolonged Hematologic Toxicity After Treatment With Cd19 Targeted Car-T Cell Therapy in Patients With Relapsed Refractory Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology